NCT00290251 2024-07-15
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
8 trialsNCT00340288 2020-01-06
Fibroid Growth Study
National Institutes of Health Clinical Center (CC)
Completed
NCT00044876 2019-12-17
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00339547 2019-07-25
Risk Factors for Uterine Fibroids: A Case Control Study
National Institutes of Health Clinical Center (CC)
Completed
NCT00341848 2019-06-17
Postpartum Uterine Regression
National Institutes of Health Clinical Center (CC)
Completed
NCT00332033 2017-07-02
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00087841 2008-01-17
Self-Hypnotic Relaxation Therapy During Invasive Procedures
National Center for Complementary and Integrative Health (NCCIH)
Phase 2 Completed
NCT00067249 2007-02-27
Women's Use of Alternative Medicine: A Multiethnic Study
National Center for Complementary and Integrative Health (NCCIH)
Completed